JournalsHub
.online
Find My Journal
JI

J. R. Infante

Independent Researcher

77
Publications
1,535
Citations
19
H-Index
33
i10-Index
0
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex + Semantic Scholar. OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Publications

0 total

Phase I study of PT-112, a novel pyrophosphate-platinum immunogenic cell death inducer, in advanced solid tumours OA

D. Karp, D. Camidge, J. Infante, T. Ames, M. Price - EClinicalMedicine, 2022
Cited by 21 Semantic Scholar

A Phase I/II Study to Assess the Safety and Efficacy of Pazopanib and Pembrolizumab Combination Therapy in Patients with Advanced Renal Cell Carcinoma. OA

S. Chowdhury, J. Infante, R. Hawkins, M. Voss, R. Perini - Clinical Genitourinary Cancer, 2021
Cited by 21 Semantic Scholar

Abstract P5-20-06: Phase 1 dose escalation with ZW25, a HER2-targeted bispecific antibody, in patients (pts) with HER2-high breast cancer (BC)

E. Hamilton, F. Meric-Bernstam, J. Infante, R. Murthy, A. Patnaik - Unknown Venue, 2018
Cited by 0 Semantic Scholar

Phase 1 study of CB-839, a small molecule inhibitor of glutaminase, in combination with everolimus in patients (pts) with clear cell and papillary renal cell cancer (RCC)

F. Meric-Bernstam, N. Tannir, J. Harding, M. Voss, J. Mier - Unknown Venue, 2016
Cited by 10 Semantic Scholar

Phase I study of safety and pharmacokinetics of the anti-MUC16 antibody-drug conjugate DMUC5754A in patients with platinum-resistant ovarian cancer or unresectable pancreatic cancer. OA

Joyce F. Liu, Kathleen N. Moore, M. Birrer, S. Berlin, U. Matulonis - Annals of Oncology, 2016
Cited by 106 Semantic Scholar

354 Phase I study of investigational oral mTORC1/2 inhibitor MLN0128: Expansion phase in patients with renal, endometrial, or bladder cancer

M. Voss, M. Gordon, M. Mita, B. Rini, V. Makker - Unknown Venue, 2015
Cited by 2 Semantic Scholar

2622 A Phase I/II study to assess the safety and efficacy of pazopanib (paz) and pembrolizumab (pembro) in patients (pts) with advanced renal cell carcinoma (aRCC)

D. McDermott, J. Infante, S. Chowdhury, M. Voss, R. Motzer - Unknown Venue, 2015
Cited by 15 Semantic Scholar

Learning and Confirming with Preclinical Studies: Modeling and Simulation in the Discovery of GDC-0917, an Inhibitor of Apoptosis Proteins Antagonist

H. Wong, S. Gould, N. Budha, W. Darbonne, E. Kadel - Drug Metabolism And Disposition, 2013
Cited by 52 Semantic Scholar

A phase I/II study of carfilzomib 2–10-min infusion in patients with advanced solid tumors OA

K. Papadopoulos, H. Burris, M. Gordon, Peter P. Lee, E. Sausville - Cancer Chemotherapy and Pharmacology, 2013
Cited by 75 Semantic Scholar

DMD053926 2104..2113

H. Wong, S. Gould, N. Budha, W. Darbonne, E. Kadel - Unknown Venue, 2013
Cited by 0 Semantic Scholar

Research Topics

Lung Cancer Treatments and Mutations (15) Cancer Treatment and Pharmacology (15) PI3K/AKT/mTOR signaling in cancer (11) Cancer therapeutics and mechanisms (10) Cancer Genomics and Diagnostics (8)

Affiliations

University of North Carolina at Chapel Hill
US 2010 - 2010
Universitat Autònoma de Barcelona
ES 2013 - 2013
Indiana University Health
US 2011 - 2011
Novartis (Switzerland)
CH 2010 - 2010
Fox Chase Cancer Center
US 2010 - 2010

External Profiles

OpenAlex Profile Semantic Scholar Profile Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now